Table of Contents Author Guidelines Submit a Manuscript
Depression Research and Treatment
Volume 2012, Article ID 469680, 7 pages
http://dx.doi.org/10.1155/2012/469680
Review Article

Approaches to Understanding and Addressing Treatment-Resistant Depression: A Scoping Review

1School of Nursing, University of BC, Vancouver, British Columbia, Canada V6T 2B5
2Centre for Applied Research in Mental Health and Addiction, Faculty of Health Sciences, Simon Fraser University, Vancouver, BC, Canada V6B 5K3

Received 8 September 2011; Revised 21 February 2012; Accepted 25 February 2012

Academic Editor: Janusz K. Rybakowski

Copyright © 2012 Emily Jenkins and Elliot M. Goldner. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Greden, “The burden of disease for treatment-resistant depression,” The Journal of Clinical Psychiatry, vol. 62, supplement 16, pp. 26–31, 2001. View at Google Scholar · View at Scopus
  2. H. A. Sackeim, “The definition and meaning of treatment-resistant depression,” The Journal of Clinical Psychiatry, vol. 62, supplement 16, pp. 10–17, 2001. View at Google Scholar · View at Scopus
  3. M. T. Berlim and G. Turecki, “Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods,” Canadian Journal of Psychiatry, vol. 52, no. 1, pp. 46–54, 2007. View at Google Scholar · View at Scopus
  4. M. T. Berlim and G. Turecki, “What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials,” European Neuropsychopharmacology, vol. 17, no. 11, pp. 696–707, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Fava, “Diagnosis and definition of treatment-resistant depression,” Biological Psychiatry, vol. 53, no. 8, pp. 649–659, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. G. A. Fava, S. Fabbri, and N. Sonino, “Residual symptoms in depression: an emerging therapeutic target,” Progress in Neuro-psychopharmacology and Biological Psychiatry, vol. 26, no. 6, pp. 1019–1027, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. L. L. Judd, H. S. Akiskal, J. D. Maser et al., “Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse,” Journal of Affective Disorders, vol. 50, no. 2-3, pp. 97–108, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Kennedy and E. S. Paykel, “Residual symptoms at remission from depression: impact on long-term outcome,” Journal of Affective Disorders, vol. 80, no. 2-3, pp. 135–144, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Greenberg, P. K. Corey-Lisle, H. Birnbaum, M. Marynchenko, and A. Claxton, “Economic implications of treatment-resistant depression among employees,” Pharmacoeconomics, vol. 22, no. 6, pp. 363–373, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Arksey and L. O'Malley, “Scoping studies: towards a methodological framework,” International Journal of Social Research Methodology: Theory and Practice, vol. 8, no. 1, pp. 19–32, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. I. M. Anderson, A. Sarsfield, and P. M. Haddad, “Efficacy, safety and tolerability of quetiapine augmentation in treatment resistant depression: an open-label, pilot study,” Journal of Affective Disorders, vol. 117, no. 1-2, pp. 116–119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. A. F. Carvalho, J. L. Cavalcante, M. S. Castelo, and M. C. O. Lima, “Augmentation strategies for treatment-resistant depression: a literature review,” Journal of Clinical Pharmacy and Therapeutics, vol. 32, no. 5, pp. 415–428, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. R. W. Lam, P. Chan, M. Wilkins-Ho, and L. N. Yatham, “Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis,” Canadian Journal of Psychiatry, vol. 53, no. 9, pp. 621–631, 2008. View at Google Scholar · View at Scopus
  14. S. Kito, K. Fujita, and Y. Koga, “Changes in regional cerebral blood flow after repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in treatment-resistant depression,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 20, no. 1, pp. 74–80, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Kito, K. Fujita, and Y. Koga, “Regional cerebral blood flow changes after low-frequency transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in treatment-resistant depression,” Neuropsychobiology, vol. 58, no. 1, pp. 29–36, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Kito, T. Hasegawa, M. Okayasu et al., “Therapeutic efficacy of transcranial magnetic stimulation in treatment-resistant depression: A three-dimensional stereotactic ROI template (3DSRT) study,” Clinical Neurophysiology, vol. 120, no. 5, article no. e153, 2009. View at Publisher · View at Google Scholar
  17. S. Kito, T. Hasegawa, K. Fujita, and Y. Koga, “Changes in hypothalamic-pituitary-thyroid axis following successful treatment with low-frequency right prefrontal transcranial magnetic stimulation in treatment-resistant depression,” Psychiatry Research, vol. 175, no. 1-2, pp. 74–77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. J. Burke and M. M. Husain, “Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression,” Journal of Ect, vol. 22, no. 3, pp. 218–222, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Sperling, J. Kornhuber, J. Wiltfang, and S. Bleich, “Combined VNS—rTMS treatment in a patient with therapy resistant depression,” Pharmacopsychiatry, vol. 40, no. 1, pp. 39–40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Maes, I. Mihaylova, M. Kubera, M. Uytterhoeven, N. Vrydags, and E. Bosmans, “Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness,” Neuroendocrinology Letters, vol. 30, no. 4, pp. 462–469, 2009. View at Google Scholar · View at Scopus
  21. L. L. Carpenter, L. Bayat, F. Moreno et al., “Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy,” Psychiatry Research, vol. 157, no. 1–3, pp. 123–129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. L. A. Carvalho, B. A. Garner, T. Dew, H. Fazakerley, and C. M. Pariante, “Antidepressants, but not antipsychotics, modulate GR function in human whole blood: an insight into molecular mechanisms,” European Neuropsychopharmacology, vol. 20, no. 6, pp. 379–387, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. F. Juruena, C. M. Pariante, A. S. Papadopoulos, L. Poon, S. Lightman, and A. J. Cleare, “Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance,” British Journal of Psychiatry, vol. 194, no. 4, pp. 342–349, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Watkins, J. Scott, J. Wingrove et al., “Rumination-focused cognitive behaviour therapy for residual depression: a case series,” Behaviour Research and Therapy, vol. 45, no. 9, pp. 2144–2154, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Matsunaga, Y. Okamoto, S. I. Suzuki et al., “Psychosocial functioning in patients with treatment-resistant depression after group cognitive behavioral therapy,” BMC Psychiatry, vol. 10, article no. 22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Viinamäki, K. Haatainen, K. Honkalampi et al., “Which factors are important predictors of non-recovery from major depression? A 2-year prospective observational study,” Nordic Journal of Psychiatry, vol. 60, no. 5, pp. 410–416, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Amital, L. Fostick, A. Silberman, M. Beckman, and B. Spivak, “Serious life events among resistant and non-resistant MDD patients,” Journal of Affective Disorders, vol. 110, no. 3, pp. 260–264, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Schramm, D. Schneider, I. Zobel et al., “Efficacy of interpersonal psychotherapy plus pharmacotherapy in chronically depressed inpatients,” Journal of Affective Disorders, vol. 109, no. 1-2, pp. 65–73, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. N. J. Wiles, S. Hollinghurst, V. Mason et al., “A randomized controlled trial of cognitive behavioural therapy as an adjunct to pharmacotherapy in primary care based patients with treatment resistant depression: a pilot study,” Behavioural and Cognitive Psychotherapy, vol. 36, no. 1, pp. 21–33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. G. S. Malhi, G. B. Parker, J. Crawford, K. Wilhelm, and P. B. Mitchell, “Treatment-resistant depression: resistant to definition?” Acta Psychiatrica Scandinavica, vol. 112, no. 4, pp. 302–309, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. M. T. Berlim, M. P. Fleck, and G. Turecki, “Current trends in the assessment and somatic treatment of resistant/refractory major depression: an overview,” Annals of Medicine, vol. 40, no. 2, pp. 149–159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. M. B. Keller, “Issues in treatment-resistant depression,” The Journal of Clinical Psychiatry, vol. 66, supplement 8, pp. 5–12, 2005. View at Google Scholar · View at Scopus
  33. B. N. Gaynes, L. Davis, A. J. Rush, M. Trivedi, M. Fava, and S. R. Wisniewski, “The aims and design of the sequenced treatment alternatives to relieve depression (STAR*D) study,” Primary Psychiatry, vol. 12, no. 2, pp. 36–41, 2005. View at Google Scholar · View at Scopus
  34. D. Warden, A. J. Rush, M. H. Trivedi, M. Fava, and S. R. Wisniewski, “The STAR*D project results: a comprehensive review of findings,” Current Psychiatry Reports, vol. 9, no. 6, pp. 449–459, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Fekadu, S. Wooderson, C. Donaldson et al., “A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method,” The Journal of Clinical Psychiatry, vol. 70, no. 2, pp. 177–184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. A. J. Rush, J. Kilner, M. Fava et al., “Clinically relevant findings from STAR*D,” Psychiatric Annals, vol. 38, no. 3, pp. 188–193, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Patten and H. Juby, A profile of clinical depression in Canada, Research Data Centre Netwo, Calgary, Canada, 2008, https://dspace.ucalgary.ca/bitstream/1880/46327/6/Patten_RSS1.pdf.
  38. S. Schwartz, “Biological approaches to psychiatric disorders,” in A Handbook for the Study of Mental Health, A. V. Horwitz and T. L. Scheid, Eds., pp. 79–102, Cambridge University Press, New York, NY, USA, 2006. View at Google Scholar
  39. C. I. Cohen, “The biomedicalization of psychiatry: a critical overview,” Community Mental Health Journal, vol. 29, no. 6, pp. 509–521, 1993. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Schramm, D. Schneider, I. Zobel et al., “Efficacy of interpersonal psychotherapy plus pharmacotherapy in chronically depressed inpatients,” Journal of Affective Disorders, vol. 109, no. 1-2, pp. 65–73, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Bannan, “Multimodal therapy of treatment resistant depression: a study and analysis,” International Journal of Psychiatry in Medicine, vol. 35, no. 1, pp. 27–39, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. S. V. Parikh, R. W. Lam, and CANMAT Depression Work Group, “Clinical practice guidelines: treatment of depressive disorders,” Canadian Journal of Psychiatry, vol. 46, S1, pp. 5S–76S, 2001. View at Google Scholar
  43. H. G. Ruhé, G. van Rooijen, J. Spijker, F. P. M. L. Peeters, and A. H. Schene, “Staging methods for treatment resistant depression. a systematic review,” Journal of Affective Disorders, 2011. View at Publisher · View at Google Scholar · View at Scopus